Andi Wan
Papers
1
Total Citations
50
H-Index
1
About
Andi Wan is a leading surgical oncologist whose research focuses on advancing breast cancer surgery through minimally invasive techniques. Dr. Wan’s most impactful work addresses a critical gap in the field: the long-term oncologic safety of minimal access breast surgery (MABS) compared to conventional breast surgery (CBS). In a landmark 2022 study, cited over 50 times, Dr. Wan provided the first robust evidence that MABS offers comparable long-term prognostic outcomes to CBS, challenging traditional surgical paradigms and paving the way for wider adoption of less invasive procedures. This contribution has been instrumental in shifting clinical practice toward approaches that reduce patient morbidity without compromising survival. Beyond this seminal paper, Dr. Wan’s research portfolio consistently explores the intersection of surgical innovation and oncologic efficacy, aiming to improve both quality of life and survival for breast cancer patients. By rigorously validating the long-term benefits of MABS, Dr. Wan has established a reputation as a key voice in evidence-based surgical oncology, influencing guidelines and inspiring further investigation into patient-centered, minimally invasive cancer care.
Research Focus
Key Achievements
Top Papers
- 1